Anlotinib to Malignant Brainstem Glioma

Clinical trial NCT04668508 · UNKNOWN

Trial details

NCT number: NCT04668508
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Brain Stem Tumor Glioma

Start date: 2020-11-24
Primary completion: 2022-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.